Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Christopher Melnic

Adult Reconstructive Orthopaedic Surgery Philadelphia, PA Medical Doctor

NPI 1205128030 CMS profile 191204

3400 Spruce St, Philadelphia, PA 19104

Open in the dashboard

General payments

$307,493

421 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Christopher Melnic of Philadelphia, PA is reported in the CMS Open Payments database as having received $307,493 across 421 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 90th percentile of Adult Reconstructive Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $90,423 90
2024 General $72,385 73
2023 General $58,711 67
2022 General $49,181 86
2021 General $31,262 69
2020 General $4,607 19
2019 General $923 17

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Christopher Melnic
  • Adult Reconstructive Orthopaedic Surgery median
  • Middle half of Adult Reconstructive Orthopaedic Surgery
  • National median

In program year 2025, general payments to Christopher Melnic were reported at $90,423. Among 1,079 Adult Reconstructive Orthopaedic Surgery profiles paid that year, the median was $1,406 and the middle half received between $318 and $8,709.

Show as a table
Year Christopher Melnic Adult Reconstructive Orthopaedic Surgery median Middle half National median
2019 $923 $1,416 $292–$9,336 $163
2020 $4,607 $647 $141–$6,474 $114
2021 $31,262 $1,073 $211–$6,497 $132
2022 $49,181 $1,217 $236–$6,299 $149
2023 $58,711 $1,082 $246–$6,818 $160
2024 $72,385 $1,575 $323–$8,944 $164
2025 $90,423 $1,406 $318–$8,709 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Smith+Nephew, Inc. $299,435 323 payments
  2. Stryker Corporation $4,044 55 payments
  3. Total Joint Orthopedics, Inc. $2,293 9 payments
  4. Zimmer Biomet Holdings, Inc. $1,303 30 payments
  5. Exactech, Inc. $418 4 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $155,963 47 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $93,113 20 payments
  3. Travel and Lodging $36,843 80 payments
  4. Food and Beverage $21,447 273 payments
  5. Education $128 1 payment
Products named General payments · program years 2019–2025
  1. REAL INTELLIGENCE $192,315 148 payments
  2. JOURNEY II Recon Knees $191,017 142 payments
  3. JOURNEY II Recon Knees $123,676 38 payments
  4. JOURNEY II Recon Knees $78,135 25 payments
  5. JOURNEY II Recon Knees $74,691 23 payments
  6. REDAPT $63,951 68 payments
  7. LEGION Revision $60,812 56 payments
  8. K-15 PORK $54,619 15 payments
  9. Engage Partial Knee System $37,770 14 payments
  10. LEGION $28,625 4 payments
  11. Other $229,491 351 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 34 billing codes

Paid by Medicare

$378,034

Of which drugs: $525

Medicare patients

636

Average age 73

Services billed

2,001

362 women, 274 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 70%
Ischemic heart disease 25%
Depression 25%
Diabetes 19%
Cancer 19%
Osteoporosis 19%
Atrial fibrillation 17%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, methylprednisolone acetate, 1 mg J1010 Office 16 760 $76

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

421 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Adult Reconstructive Orthopaedic Surgery in Pennsylvania

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record